221 related articles for article (PubMed ID: 18384710)
1. The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trials.
Coleman CI; Reinhart K; Kluger J; White CM
Curr Med Res Opin; 2008 May; 24(5):1359-62. PubMed ID: 18384710
[TBL] [Abstract][Full Text] [Related]
2. Impact of gender on statin efficacy.
Dale KM; Coleman CI; Shah SA; Patel AA; Kluger J; White CM
Curr Med Res Opin; 2007 Mar; 23(3):565-74. PubMed ID: 17355737
[TBL] [Abstract][Full Text] [Related]
3. Risk of new-onset diabetes among patients treated with statins according to hypertension and gender: Results from a nationwide health-screening cohort.
Lee SE; Sung JM; Cho IJ; Kim HC; Chang HJ
PLoS One; 2018; 13(4):e0195459. PubMed ID: 29630642
[TBL] [Abstract][Full Text] [Related]
4. Statin use and the risk of developing diabetes: a network meta-analysis.
Thakker D; Nair S; Pagada A; Jamdade V; Malik A
Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1131-1149. PubMed ID: 27277934
[TBL] [Abstract][Full Text] [Related]
5. Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.
Vrecer M; Turk S; Drinovec J; Mrhar A
Int J Clin Pharmacol Ther; 2003 Dec; 41(12):567-77. PubMed ID: 14692706
[TBL] [Abstract][Full Text] [Related]
6. Statins and risk of new-onset diabetes mellitus.
Shah RV; Goldfine AB
Circulation; 2012 Oct; 126(18):e282-4. PubMed ID: 23109518
[No Abstract] [Full Text] [Related]
7. Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials.
Naci H; Brugts J; Ades T
Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):390-9. PubMed ID: 23838105
[TBL] [Abstract][Full Text] [Related]
8. Association between reductions in low-density lipoprotein cholesterol with statin therapy and the risk of new-onset diabetes: a meta-analysis.
Wang S; Cai R; Yuan Y; Varghese Z; Moorhead J; Ruan XZ
Sci Rep; 2017 Jan; 7():39982. PubMed ID: 28071756
[TBL] [Abstract][Full Text] [Related]
9. Do statins really cause diabetes? A meta-analysis of major randomized controlled clinical trials.
Rahal AJ; ElMallah AI; Poushuju RJ; Itani R
Saudi Med J; 2016 Oct; 37(10):1051-60. PubMed ID: 27652354
[TBL] [Abstract][Full Text] [Related]
10. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.
Sattar N; Preiss D; Murray HM; Welsh P; Buckley BM; de Craen AJ; Seshasai SR; McMurray JJ; Freeman DJ; Jukema JW; Macfarlane PW; Packard CJ; Stott DJ; Westendorp RG; Shepherd J; Davis BR; Pressel SL; Marchioli R; Marfisi RM; Maggioni AP; Tavazzi L; Tognoni G; Kjekshus J; Pedersen TR; Cook TJ; Gotto AM; Clearfield MB; Downs JR; Nakamura H; Ohashi Y; Mizuno K; Ray KK; Ford I
Lancet; 2010 Feb; 375(9716):735-42. PubMed ID: 20167359
[TBL] [Abstract][Full Text] [Related]
11. Impact of statin therapy on plasma leptin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials.
Sahebkar A; Giua R; Pedone C
Br J Clin Pharmacol; 2016 Dec; 82(6):1674-1684. PubMed ID: 27509867
[TBL] [Abstract][Full Text] [Related]
12. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
13. Statin-associated incident diabetes: a literature review.
Park ZH; Juska A; Dyakov D; Patel RV
Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
[TBL] [Abstract][Full Text] [Related]
14. Effect of pitavastatin on glucose, HbA1c and incident diabetes: A meta-analysis of randomized controlled clinical trials in individuals without diabetes.
Vallejo-Vaz AJ; Kondapally Seshasai SR; Kurogi K; Michishita I; Nozue T; Sugiyama S; Tsimikas S; Yoshida H; Ray KK
Atherosclerosis; 2015 Aug; 241(2):409-18. PubMed ID: 26074315
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of the effects of statin therapy on endothelial function in patients with diabetes mellitus.
Zhang L; Gong D; Li S; Zhou X
Atherosclerosis; 2012 Jul; 223(1):78-85. PubMed ID: 22326029
[TBL] [Abstract][Full Text] [Related]
16. Statin therapy and risk of developing type 2 diabetes: a meta-analysis.
Rajpathak SN; Kumbhani DJ; Crandall J; Barzilai N; Alderman M; Ridker PM
Diabetes Care; 2009 Oct; 32(10):1924-9. PubMed ID: 19794004
[TBL] [Abstract][Full Text] [Related]
17. Statins and diabetes risk: fact, fiction, and clinical implications.
Rocco MB
Cleve Clin J Med; 2012 Dec; 79(12):883-93. PubMed ID: 23208994
[TBL] [Abstract][Full Text] [Related]
18. Putting the diabetes risk due to statins in perspective: a re-evaluation using the complementary outcome.
Furuya-Kanamori L; Stone JC; Doi SA
Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):705-8. PubMed ID: 24780516
[TBL] [Abstract][Full Text] [Related]
19. The relationship between statin use and atrial fibrillation.
Patel AA; White CM; Shah SA; Dale KM; Kluger J; Coleman CI
Curr Med Res Opin; 2007 May; 23(5):1177-85. PubMed ID: 17519085
[TBL] [Abstract][Full Text] [Related]
20. Statins and cancer risk.
Karp I; Behlouli H; Lelorier J; Pilote L
Am J Med; 2008 Apr; 121(4):302-9. PubMed ID: 18374689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
